Quick answer
Tg Therapeutics, Inc. (TGTX) reported diluted EPS of $0.05 for the quarter ended 2026-06-30, in a 10-Q filed with the SEC on 2026-08-05. Its last four 10-Q/10-K filings were on 2026-08-05, 2026-05-06, 2026-02-27, 2025-11-05.
Data as of 2026-08-05. Source: SEC EDGAR XBRL company facts (10-K/10-Q filings)
| Period end | Period | Form | SEC filing date | Diluted EPS |
|---|---|---|---|---|
| 2026-06-30 | Quarter | 10-Q | 2026-08-05 | $0.05 |
| 2026-03-31 | Quarter | 10-Q | 2026-05-06 | $0.12 |
| 2025-12-31 | Full year | 10-K | 2026-02-27 | $2.77 |
| 2025-09-30 | Quarter | 10-Q | 2025-11-05 | $2.43 |
| 2025-06-30 | Quarter | 10-Q | 2025-08-08 | $0.17 |
| 2025-03-31 | Quarter | 10-Q | 2025-05-09 | $0.03 |
| 2024-12-31 | Full year | 10-K | 2025-03-03 | $0.15 |
| 2024-09-30 | Quarter | 10-Q | 2024-11-07 | $0.02 |
| 2024-06-30 | Quarter | 10-Q | 2024-08-09 | $0.04 |
| 2024-03-31 | Quarter | 10-Q | 2025-05-09 | $-0.07 |
| 2023-12-31 | Full year | 10-K | 2024-02-29 | $0.09 |
| 2023-09-30 | Quarter | 10-Q | 2023-11-06 | $0.73 |
| 2023-06-30 | Quarter | 10-Q | 2023-08-04 | $-0.34 |
| 2023-03-31 | Quarter | 10-Q | 2023-05-08 | $-0.28 |
| 2022-12-31 | Full year | 10-K | 2023-03-01 | $-1.46 |
| 2022-09-30 | Quarter | 10-Q | 2022-11-09 | $-0.26 |
Related
- TEVA earnings report dates and EPS history (Teva Pharmaceutical Industries Limited)
- TFC earnings report dates and EPS history (Truist Financial Corporation)
- TGT earnings report dates and EPS history (Target Corporation)
- THC earnings report dates and EPS history (Tenet Healthcare Corp)
- THG earnings report dates and EPS history (Hanover Insurance Group, Inc.)
- TJX earnings report dates and EPS history (The TJX Companies, Inc.)
- TKO earnings report dates and EPS history (Tko Group Holdings, Inc.)
- TLN earnings report dates and EPS history (Talen Energy Corporation)
Last updated 2026-10-16. Data only, not financial or tax advice.